A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - Clinical protocol

Yi Zeng, Anna Barbara Moscicki, Vikrant V. Sahasrabuddhe, Francisco Garcia, Heide Woo, Chiu Hsieh Hsu, Eva Szabo, Eileen DImond, Susan Vanzzini, Angelica Mondragon, Valerie Butler, Hillary DeRose, H. H.Sherry Chow

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - Clinical protocol'. Together they form a unique fingerprint.

Medicine & Life Sciences